Colossal Biosciences expands its de-extinction mission by acquiring Viagen, the world leader in animal cloning and species preservation.

Colossal’s purchase of ViaGen, known for cloning pets of celebrities, bolsters the biotech firm’s tools for de-extinction and conservation.

Viagen isn't just a pet cloning service; it's a powerhouse whose history is intertwined with cloning breakthroughs.

Larry Mantle talks with Greg Stock, best-selling author, and reproductive biology expert about his new book, Redesigning Humans (Houghton Mifflin). Stock considers how the human race is likely to change as a result of the coming advances in science, weighs ...

Back when it was no more than a cheesy science-fiction plot device, human cloning seemed like something that would eventually be revealed to a horrified world full-blown and fully grown–a monstrous carnival apparition (“The Amazing Cloned Boy!”